MindMaze, a global leader in digital medicine for brain health, and Mount Sinai Health System, one of the largest academic medical systems in the New York metro area, are partnering to pioneer a digital therapeutic program that will accelerate neurological patient...
MindMaze, a provider of digital therapeutics (DTx) for neurological recovery and care, in partnership with The University of Auckland, announces a new interventional study that will aim to show the merits of early, immersive, and intensive intervention to recover...
MindMaze Healthcare has been granted Current Procedural Terminology (CPT) Category III codes published by the American Medical Association (AMA) on November 1, 2021 and effective July 1, 2022 for the MindMotion GO. Healthcare providers will now be able to submit...
MindMaze Healthcare announces four new partnership agreements that bring MindMaze’s digital neurotherapeutics to patients in Latin America, Middle East, Spain and Switzerland through agreements with Surgicorp, Alkholi, Guttmann...
MindMaze’s acquisition of Neuro Motor Innovations Corporation (NMI) aims to significantly advance recovery for patients suffering from neurological diseases and injuries, the company announces. NMI combines neuroscience and a novel form of animation –...
